Promega Corporation designs and manufactures: cell-based assays that deliver more biologically relevant data for basic research, drug discovery, and screening applications including mechanistic toxicity, ADME, biologics bioassays, reporter technologies for cell signaling to protein interactions; novel protein function and analysis systems; manual to automated nucleic acid purification for research, biobanking and clinical applications; with custom assay design services and GMP capability.